Veeva Systems [VEEV] vs Doximity [DOCS] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Veeva Systems wins in 10 metrics, Doximity wins in 9 metrics, with 0 ties. Veeva Systems appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricVeeva SystemsDoximityBetter
P/E Ratio (TTM)58.8963.66Veeva Systems
Price-to-Book Ratio7.2413.73Veeva Systems
Debt-to-Equity Ratio1.291.16Doximity
PEG Ratio3.672.33Doximity
EV/EBITDA48.8754.29Veeva Systems
Profit Margin (TTM)27.29%39.88%Doximity
Operating Margin (TTM)28.71%37.48%Doximity
EBITDA Margin (TTM)28.71%37.48%Doximity
Return on Equity13.70%24.25%Doximity
Return on Assets (TTM)7.24%13.13%Doximity
Free Cash Flow (TTM)$1.09B$266.74MVeeva Systems
1-Year Return46.96%66.89%Doximity
Price-to-Sales Ratio (TTM)16.1923.63Veeva Systems
Enterprise Value$42.51B$13.24BVeeva Systems
EV/Revenue Ratio14.3222.46Veeva Systems
Gross Profit Margin (TTM)75.26%89.18%Doximity
Revenue per Share (TTM)$18$3Veeva Systems
Earnings per Share (Diluted)$4.98$1.18Veeva Systems
Beta (Stock Volatility)0.951.37Veeva Systems
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Veeva Systems vs Doximity Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Veeva Systems2.57%7.45%11.41%6.43%32.78%42.84%
Doximity1.91%-3.21%7.45%21.38%24.23%34.41%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Veeva Systems46.96%81.38%2.27%1,066.76%577.61%577.61%
Doximity66.89%146.55%30.67%30.67%30.67%30.67%

News Based Sentiment: Veeva Systems vs Doximity

Veeva Systems

News based Sentiment: POSITIVE

Veeva demonstrated strong financial results and continued expansion of its CRM platform within the biopharma industry, despite a minor stock decline. The upcoming Investor Day presents an opportunity for management to articulate their vision and reinforce investor confidence.

View Veeva Systems News Sentiment Analysis

Doximity

News based Sentiment: MIXED

October brought a mix of positive financial projections and concerning signals for Doximity. While the company is expected to continue growing revenue and earnings, a downgrade from Goldman Sachs, significant insider selling, and potential regulatory risks create uncertainty. This combination of factors makes October a significant month for investors to reassess their positions.

View Doximity News Sentiment Analysis

Performance & Financial Health Analysis: Veeva Systems vs Doximity

MetricVEEVDOCS
Market Information
Market Cap i$48.07B$14.07B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i1,264,8001,577,510
90 Day Avg. Volume i1,442,0371,326,787
Last Close$300.79$71.99
52 Week Range$200.30 - $300.88$40.87 - $85.21
% from 52W High-0.03%-15.51%
All-Time High$343.96 (Aug 02, 2021)$107.79 (Sep 06, 2021)
% from All-Time High-12.55%-33.21%
Growth Metrics
Quarterly Revenue Growth0.17%0.15%
Quarterly Earnings Growth0.17%0.29%
Financial Health
Profit Margin (TTM) i0.27%0.40%
Operating Margin (TTM) i0.29%0.37%
Return on Equity (TTM) i0.14%0.24%
Debt to Equity (MRQ) i1.291.16
Cash & Liquidity
Book Value per Share (MRQ)$40.51$5.47
Cash per Share (MRQ)$39.07$4.49
Operating Cash Flow (TTM) i$1.35B$294.12M
Levered Free Cash Flow (TTM) i$1.10B$231.29M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Veeva Systems vs Doximity

MetricVEEVDOCS
Price Ratios
P/E Ratio (TTM) i58.8963.66
Forward P/E i43.3863.13
PEG Ratio i3.672.33
Price to Sales (TTM) i16.1923.63
Price to Book (MRQ) i7.2413.73
Market Capitalization
Market Capitalization i$48.07B$14.07B
Enterprise Value i$42.51B$13.24B
Enterprise Value Metrics
Enterprise to Revenue i14.3222.46
Enterprise to EBITDA i48.8754.29
Risk & Other Metrics
Beta i0.951.37
Book Value per Share (MRQ) i$40.51$5.47

Financial Statements Comparison: Veeva Systems vs Doximity

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)VEEVDOCS
Revenue/Sales i$759.04M$145.91M
Cost of Goods Sold i$173.82M$15.79M
Gross Profit i$585.22M$130.12M
Research & Development i$184.03M$26.80M
Operating Income (EBIT) i$233.73M$54.52M
EBITDA i$243.55M$57.31M
Pre-Tax Income i$298.82M$64.15M
Income Tax i$70.63M$10.83M
Net Income (Profit) i$228.19M$53.32M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)VEEVDOCS
Cash & Equivalents i$1.96B$209.61M
Total Current Assets i$6.71B$1.09B
Total Current Liabilities i$1.46B$156.26M
Long-Term Debt i$66.57M$10.19M
Total Shareholders Equity i$6.21B$1.08B
Retained Earnings i$3.68B$186.89M
Property, Plant & Equipment i$122.23M$8.89M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)VEEVDOCS
Operating Cash Flow i$810.54M$119.90M
Capital Expenditures iN/A$0
Free Cash Flow i$877.16M$96.98M
Debt Repayment iN/AN/A
Common Stock Repurchase iN/A$-26.79M

Short Interest & Institutional Ownership Analysis

MetricVEEVDOCS
Shares Short i5.41M4.82M
Short Ratio i3.603.93
Short % of Float i0.04%0.04%
Average Daily Volume (10 Day) i1,264,8001,577,510
Average Daily Volume (90 Day) i1,442,0371,326,787
Shares Outstanding i162.58M188.88M
Float Shares i150.41M133.22M
% Held by Insiders i0.09%0.02%
% Held by Institutions i0.89%0.91%

Dividend Analysis & Yield Comparison: Veeva Systems vs Doximity

MetricVEEVDOCS
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A